Skip to content

Role of Tilanal kshara in the treatment of Pittashaya Ashmari(Gall Bladder Stone)

To Assess The Efficacy Of Tilanal Paniya Kshara In The Management Of Cholelithiasis With Special Reference To Pittashaya Ashmari

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022688
Enrollment
36
Registered
2020-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K80- Cholelithiasis

Interventions

Intervention1: Tilanal paniya kshara: Dosage(Age group 20 to 60)-250mg in two divided dose after meal Route of adminstration Oral Duration of drug intervention -4 weeks with Takra Control Intervention

Sponsors

parul institute of ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having classical sign and symptoms of cholelithiasis. 2.Asymptomatic patients who are diagnosed to have gall stones, accidentally by usg. 3.Age between 20 to 60 years. 4.Subjects of either gender. 5.Solitary or multiple stones (1 to 20 mm in size)

Exclusion criteria

Exclusion criteria: 1. Patients who are contraindication (Ayogya) for Paniya kshara. 2.Patients with cholelithiasis with complications such as acute obstructive cholecystitis,Acute pancreatitis, Liver failure and carcinoma of gall bladder. 3.The gall stones which are present in the cystic duct and CBD 4.Subjects with congenital anomalies of hepatobiliary system. 5.Uncontrolled other systemic disorders like Diabetes mellitus , hypertension etc.

Design outcomes

Primary

MeasureTime frame
Tilanal kshara(Paniya)is efective in the management of pittashaya ashmari(Cholelithiasis)Timepoint: 4 weeks(28 days)

Secondary

MeasureTime frame
NillTimepoint: Nill

Countries

India

Contacts

Public ContactDr Durgesh Kumar Saini

parul institute of ayurveda

goldparx@gmail.com9960063588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026